Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,144 | 10,944 | 11,911 | 13,468 | 15,638 |
| TOTAL | $9,144 | $10,944 | $11,911 | $13,468 | $15,638 |
| Non-Current Assets | |||||
| Intangibles | 6 | 7 | 8 | 9 | 10 |
| TOTAL | $6 | $7 | $8 | $9 | $10 |
| Total Assets | $9,150 | $10,951 | $11,919 | $13,477 | $15,648 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 231 | 301 | 221 | 221 | 221 |
| Other current liabilities | 66 | 1 | 15 | 42 | 17 |
| TOTAL | $297 | $302 | $236 | $263 | $238 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $297 | $302 | $236 | $263 | $238 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,848 | 12,848 | 12,848 | 12,848 | 12,848 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -47,618 | -45,226 | -43,598 | -41,473 | -38,682 |
| TOTAL | $8,853 | $10,650 | $11,684 | $13,214 | $15,410 |
| Total Liabilities And Equity | $9,150 | $10,951 | $11,919 | $13,477 | $15,648 |